Home » Topics » BioWorld Science

BioWorld Science
RSS

Carbapenem from Merck & Co. undergoing extensive evaluation

Oct. 4, 1996

P&G describes quinolonyl-cephem dithiocarbamates

Oct. 4, 1996

Cephalosporin-bridged carbacephem combinations evaluated by Roche

Oct. 4, 1996

Combined beta-lactamase inhibitor/antibacterial agent from Roche

Oct. 4, 1996

Bridged carbacephems from Roche for use in combination with cephalosporins

Oct. 4, 1996

Fujisawa describes orally active cephalosporin

Oct. 4, 1996

Hydroxypyridone cephalosporins described by Kyorin

Oct. 4, 1996

Takeda discloses cephem antibacterial compounds

Oct. 4, 1996

New antiacne bacteriocin

Oct. 4, 1996

Merck & Co. reports 5-HT1Dalpha receptor agonists

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026